_id
69131468ccc777a4e85d7ffa
Ticker
MDNC
Name
Medinotec Inc.
Exchange
PINK
Address
Northlands Deco Park, Johannesburg, South Africa, 2169
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://www.medinotecinc.com
Description
Medinotec Inc. engages in the research and development, production, and sale of medical devices for the treatment of vascular and airway diseases in South Africa, the United States, and internationally. The company offers semi-compliant percutaneous transluminal coronary angioplasty balloon catheters, suction dissectors, aortic perfusion and dilation catheters, chronic total occlusion catheters, and silicone tracheal stents. It serves hospitals, clinics, third-party healthcare providers, distributors, and other institutions, including governmental healthcare programs and group purchasing organizations. The company sells its products through the network of distributors and direct sales force. Medinotec Inc. was incorporated in 2021 and is headquartered in Johannesburg, South Africa.
Last Close
5
Volume
-
Current Price
5
Change
0
Last Updated
2026-01-05T10:17:50.291Z
Image
-
Ipo Date
-
Market Cap
58777740
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-05-31
Revenue
2134026
Cost Of Revenue
1208695
Gross Profit
925331
Operating Expenses
1856569
Operating Income
277457
Interest Expense
31925
Pretax Income
262772
Net Income
113784
Eps
0.009697155640779801
Dividends Per Share
-
Shares Outstanding
11755548
Income Tax Expense
-
EBITDA
-
Operating Margin
13.001575425978878
Total Other Income Expense Net
16421
Cash
1950876
Short Term Investments
-
Receivables
3886756
Inventories
928070
Total Current Assets
6955491
Property Plant Equipment
376578
Total Assets
7404026
Payables
1169343
Short Term Debt
-
Long Term Debt
938659
Total Liabilities
3035204
Equity
4368822
Bs_currency_symbol
USD
Depreciation
7506
Change In Working Capital
-1030095
Cash From Operations
-759238
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-37900
Net Change In Cash
-818809
Cf_currency_symbol
USD
PE
27.7778
PB
13.428963230820573
ROE
2.6044549308715257
ROA
1.536785527225323
FCF
-759238
Fcf Percent
-0.3557772960591858
Piotroski FScore
2
Health Score
41
Deep Value Investing Score
3
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2
Growth Investing Score
1.5
Momentum Investing Score
7
Net Net Investing Score
2.5
Quality Investing Score
4.5
Value Investing Score
5
Quarters > 0 > quarter
2025-05-31
Quarters > 0 > income Statement > revenue
2134026
Quarters > 0 > income Statement > cost Of Revenue
1208695
Quarters > 0 > income Statement > gross Profit
925331
Quarters > 0 > income Statement > operating Expenses
1856569
Quarters > 0 > income Statement > operating Income
277457
Quarters > 0 > income Statement > interest Expense
31925
Quarters > 0 > income Statement > pretax Income
262772
Quarters > 0 > income Statement > net Income
113784
Quarters > 0 > income Statement > eps
0.009697155640779801
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
11733750
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
13.001575425978878
Quarters > 0 > income Statement > total Other Income Expense Net
16421
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
1950876
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
3886756
Quarters > 0 > balance Sheet > inventories
928070
Quarters > 0 > balance Sheet > total Current Assets
6955491
Quarters > 0 > balance Sheet > property Plant Equipment
376578
Quarters > 0 > balance Sheet > total Assets
7404026
Quarters > 0 > balance Sheet > payables
1169343
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
938659
Quarters > 0 > balance Sheet > total Liabilities
3035204
Quarters > 0 > balance Sheet > equity
4368822
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
113784
Quarters > 0 > cash Flow > depreciation
7506
Quarters > 0 > cash Flow > change In Working Capital
-1030095
Quarters > 0 > cash Flow > cash From Operations
-759238
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-37900
Quarters > 0 > cash Flow > net Change In Cash
-818809
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
0.009697155640779801
Quarters > 0 > ratios > PB
13.428963230820573
Quarters > 0 > ratios > ROE
2.6044549308715257
Quarters > 0 > ratios > ROA
1.536785527225323
Quarters > 0 > ratios > FCF
-759238
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-0.3557772960591858
Quarters > 0 > health Score
41
Quarters > 1 > quarter
2025-02-28
Quarters > 1 > income Statement > revenue
3525162
Quarters > 1 > income Statement > cost Of Revenue
1138842
Quarters > 1 > income Statement > gross Profit
2386320
Quarters > 1 > income Statement > operating Expenses
1526192
Quarters > 1 > income Statement > operating Income
1998970
Quarters > 1 > income Statement > interest Expense
27909
Quarters > 1 > income Statement > pretax Income
1923491
Quarters > 1 > income Statement > net Income
1477209
Quarters > 1 > income Statement > eps
0.12589402364972835
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
11733750
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
56.705762742251274
Quarters > 1 > income Statement > total Other Income Expense Net
-11322
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
2769686
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
2612440
Quarters > 1 > balance Sheet > inventories
988341
Quarters > 1 > balance Sheet > total Current Assets
6423186
Quarters > 1 > balance Sheet > property Plant Equipment
385787
Quarters > 1 > balance Sheet > total Assets
6808973
Quarters > 1 > balance Sheet > payables
1198953
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
940277
Quarters > 1 > balance Sheet > total Liabilities
2538144
Quarters > 1 > balance Sheet > equity
4270829
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
1477209
Quarters > 1 > cash Flow > depreciation
-657
Quarters > 1 > cash Flow > change In Working Capital
-1931149
Quarters > 1 > cash Flow > cash From Operations
98715
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-50927
Quarters > 1 > cash Flow > net Change In Cash
93161
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
0.12589402364972835
Quarters > 1 > ratios > PB
13.73708710884936
Quarters > 1 > ratios > ROE
34.58834338719719
Quarters > 1 > ratios > ROA
21.695033891307837
Quarters > 1 > ratios > FCF
98715
Quarters > 1 > ratios > Piotroski FScore
3
Quarters > 1 > ratios > fcf Percent
0.028002968374219398
Quarters > 1 > health Score
64
Quarters > 2 > quarter
2024-11-30
Quarters > 2 > income Statement > revenue
2565048
Quarters > 2 > income Statement > cost Of Revenue
1524272
Quarters > 2 > income Statement > gross Profit
1040776
Quarters > 2 > income Statement > operating Expenses
2051281
Quarters > 2 > income Statement > operating Income
513767
Quarters > 2 > income Statement > interest Expense
43400
Quarters > 2 > income Statement > pretax Income
481474
Quarters > 2 > income Statement > net Income
310311
Quarters > 2 > income Statement > eps
0.026446021093000958
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
11733750
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
20.02952771254183
Quarters > 2 > income Statement > total Other Income Expense Net
-3621
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
2676525
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
992464
Quarters > 2 > balance Sheet > inventories
1151466
Quarters > 2 > balance Sheet > total Current Assets
4920314
Quarters > 2 > balance Sheet > property Plant Equipment
423732
Quarters > 2 > balance Sheet > total Assets
5362621
Quarters > 2 > balance Sheet > payables
996702
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
1041090
Quarters > 2 > balance Sheet > total Liabilities
2536789
Quarters > 2 > balance Sheet > equity
2825832
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
310311
Quarters > 2 > cash Flow > depreciation
25966
Quarters > 2 > cash Flow > change In Working Capital
-207389
Quarters > 2 > cash Flow > cash From Operations
124510
Quarters > 2 > cash Flow > capital Expenditures
72626
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-109684
Quarters > 2 > cash Flow > net Change In Cash
-81800
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
0.026446021093000958
Quarters > 2 > ratios > PB
20.761584552797196
Quarters > 2 > ratios > ROE
10.98122606014795
Quarters > 2 > ratios > ROA
5.786554746270527
Quarters > 2 > ratios > FCF
51884
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
0.020227301789284256
Quarters > 2 > health Score
52
Quarters > 3 > quarter
2024-08-31
Quarters > 3 > income Statement > revenue
1804020
Quarters > 3 > income Statement > cost Of Revenue
970608
Quarters > 3 > income Statement > gross Profit
833412
Quarters > 3 > income Statement > operating Expenses
1381480
Quarters > 3 > income Statement > operating Income
422540
Quarters > 3 > income Statement > interest Expense
47085
Quarters > 3 > income Statement > pretax Income
405029
Quarters > 3 > income Statement > net Income
284749
Quarters > 3 > income Statement > eps
0.02426751890912965
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
11733750
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
23.422135009589695
Quarters > 3 > income Statement > total Other Income Expense Net
14154
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
2758325
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
771368
Quarters > 3 > balance Sheet > inventories
1271843
Quarters > 3 > balance Sheet > total Current Assets
4902075
Quarters > 3 > balance Sheet > property Plant Equipment
379982
Quarters > 3 > balance Sheet > total Assets
5295834
Quarters > 3 > balance Sheet > payables
1342555
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
1171533
Quarters > 3 > balance Sheet > total Liabilities
2766109
Quarters > 3 > balance Sheet > equity
2529725
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
284749
Quarters > 3 > cash Flow > depreciation
25309
Quarters > 3 > cash Flow > change In Working Capital
12276
Quarters > 3 > cash Flow > cash From Operations
408426
Quarters > 3 > cash Flow > capital Expenditures
11678
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-192330
Quarters > 3 > cash Flow > net Change In Cash
239242
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
0.02426751890912965
Quarters > 3 > ratios > PB
23.1917500914131
Quarters > 3 > ratios > ROE
11.256124677583532
Quarters > 3 > ratios > ROA
5.376849047760938
Quarters > 3 > ratios > FCF
396748
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.2199243910821388
Quarters > 3 > health Score
65
Annuals > 0 > quarter
2025-02-28
Annuals > 0 > income Statement > revenue
9113607
Annuals > 0 > income Statement > cost Of Revenue
4252821
Annuals > 0 > income Statement > gross Profit
4860786
Annuals > 0 > income Statement > operating Expenses
5922108
Annuals > 0 > income Statement > operating Income
3191499
Annuals > 0 > income Statement > interest Expense
176416
Annuals > 0 > income Statement > pretax Income
3024138
Annuals > 0 > income Statement > net Income
2159473
Annuals > 0 > income Statement > eps
0.184039458826036
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
11733750
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
35.019054475357564
Annuals > 0 > income Statement > total Other Income Expense Net
387
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
2769686
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
2612440
Annuals > 0 > balance Sheet > inventories
988341
Annuals > 0 > balance Sheet > total Current Assets
6423186
Annuals > 0 > balance Sheet > property Plant Equipment
385787
Annuals > 0 > balance Sheet > total Assets
6808973
Annuals > 0 > balance Sheet > payables
1198953
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
940277
Annuals > 0 > balance Sheet > total Liabilities
2538144
Annuals > 0 > balance Sheet > equity
4270829
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
2159473
Annuals > 0 > cash Flow > depreciation
73846
Annuals > 0 > cash Flow > change In Working Capital
-1915974
Annuals > 0 > cash Flow > cash From Operations
877834
Annuals > 0 > cash Flow > capital Expenditures
89013
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-894482
Annuals > 0 > cash Flow > net Change In Cash
-39224
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
0.184039458826036
Annuals > 0 > ratios > PB
13.73708710884936
Annuals > 0 > ratios > ROE
50.563321547175036
Annuals > 0 > ratios > ROA
31.715105934477933
Annuals > 0 > ratios > FCF
788821
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.0865542040599293
Annuals > 0 > health Score
71
Annuals > 1 > quarter
2024-02-29
Annuals > 1 > income Statement > revenue
5020391
Annuals > 1 > income Statement > cost Of Revenue
2577922
Annuals > 1 > income Statement > gross Profit
2442469
Annuals > 1 > income Statement > operating Expenses
5061825
Annuals > 1 > income Statement > operating Income
-41434
Annuals > 1 > income Statement > interest Expense
277230
Annuals > 1 > income Statement > pretax Income
-253770
Annuals > 1 > income Statement > net Income
-404688
Annuals > 1 > income Statement > eps
-0.034489229785874084
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
11733750
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-0.825314203614818
Annuals > 1 > income Statement > total Other Income Expense Net
4304
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
2808910
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
589761
Annuals > 1 > balance Sheet > inventories
863452
Annuals > 1 > balance Sheet > total Current Assets
4379297
Annuals > 1 > balance Sheet > property Plant Equipment
382101
Annuals > 1 > balance Sheet > total Assets
4804279
Annuals > 1 > balance Sheet > payables
588640
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
1769957
Annuals > 1 > balance Sheet > total Liabilities
2637108
Annuals > 1 > balance Sheet > equity
2167171
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-404688
Annuals > 1 > cash Flow > depreciation
88225
Annuals > 1 > cash Flow > change In Working Capital
-500912
Annuals > 1 > cash Flow > cash From Operations
14242
Annuals > 1 > cash Flow > capital Expenditures
2255
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-8092
Annuals > 1 > cash Flow > net Change In Cash
-18547
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.034489229785874084
Annuals > 1 > ratios > PB
27.07158318379122
Annuals > 1 > ratios > ROE
-18.6735610618636
Annuals > 1 > ratios > ROA
-8.42349080892263
Annuals > 1 > ratios > FCF
11987
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
0.002387662634245022
Annuals > 1 > health Score
16
Annuals > 2 > quarter
2023-02-28
Annuals > 2 > income Statement > revenue
999579
Annuals > 2 > income Statement > cost Of Revenue
417757
Annuals > 2 > income Statement > gross Profit
581822
Annuals > 2 > income Statement > operating Expenses
1238166
Annuals > 2 > income Statement > operating Income
-238587
Annuals > 2 > income Statement > interest Expense
226814
Annuals > 2 > income Statement > pretax Income
-391477
Annuals > 2 > income Statement > net Income
-352735
Annuals > 2 > income Statement > eps
-0.030061574517950357
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
11733750
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-103513
Annuals > 2 > income Statement > operating Margin
-23.8687487432209
Annuals > 2 > income Statement > total Other Income Expense Net
51417
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
2827457
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
21074
Annuals > 2 > balance Sheet > inventories
354304
Annuals > 2 > balance Sheet > total Current Assets
3369478
Annuals > 2 > balance Sheet > property Plant Equipment
406873
Annuals > 2 > balance Sheet > total Assets
4490432
Annuals > 2 > balance Sheet > payables
53615
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
1863066
Annuals > 2 > balance Sheet > total Liabilities
1934377
Annuals > 2 > balance Sheet > equity
2556055
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-352735
Annuals > 2 > cash Flow > depreciation
53553
Annuals > 2 > cash Flow > change In Working Capital
-74108
Annuals > 2 > cash Flow > cash From Operations
-490549
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
3577194
Annuals > 2 > cash Flow > net Change In Cash
2695880
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.030061574517950357
Annuals > 2 > ratios > PB
22.952851171042877
Annuals > 2 > ratios > ROE
-13.799976917554591
Annuals > 2 > ratios > ROA
-7.855257578780838
Annuals > 2 > ratios > FCF
-490549
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-0.49075560811101476
Annuals > 2 > health Score
23
Annuals > 3 > quarter
2022-02-28
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
-
Annuals > 3 > income Statement > operating Income
-
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-
Annuals > 3 > income Statement > net Income
-
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
11733750
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
131577
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
42183
Annuals > 3 > balance Sheet > inventories
438923
Annuals > 3 > balance Sheet > total Current Assets
10164
Annuals > 3 > balance Sheet > property Plant Equipment
515703
Annuals > 3 > balance Sheet > total Assets
1323031
Annuals > 3 > balance Sheet > payables
160687
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
1583997
Annuals > 3 > balance Sheet > total Liabilities
1793016
Annuals > 3 > balance Sheet > equity
-469985
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-732
Annuals > 3 > cash Flow > depreciation
-
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-732
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
12390
Annuals > 3 > cash Flow > net Change In Cash
12197
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-124.83111163122227
Annuals > 3 > ratios > ROE
-
Annuals > 3 > ratios > ROA
-
Annuals > 3 > ratios > FCF
-732
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
41
Valuation > metrics > PE
27.7778
Valuation > metrics > PB
13.428963230820573
Valuation > final Score
16.66664
Valuation > verdict
179.4% Overvalued
Profitability > metrics > ROE
2.6044549308715257
Profitability > metrics > ROA
1.63588738738933
Profitability > metrics > Net Margin
0.05331893800731575
Profitability > final Score
18
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.6947419693455124
Risk > metrics > Interest Coverage
8.69090054815975
Risk > final Score
83
Risk > verdict
Low
Liquidity > metrics > Current Ratio
5.948204248026456
Liquidity > metrics > Quick Ratio
5.154536350754227
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
40
Prev Profitabilities > 0
100
Prev Profitabilities > 1
59
Prev Profitabilities > 2
64
Prev Risks > 0
88
Prev Risks > 1
88
Prev Risks > 2
66
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:11:29.284Z
Medinotec Inc. engages in the research and development, production, and sale of medical devices for the treatment of vascular and airway diseases in South Africa, the United States, and internationally. The company offers semi-compliant percutaneous transluminal coronary angioplasty balloon catheters, suction dissectors, aortic perfusion and dilation catheters, chronic total occlusion catheters, and silicone tracheal stents. It serves hospitals, clinics, third-party healthcare providers, distributors, and other institutions, including governmental healthcare programs and group purchasing organizations. The company sells its products through the network of distributors and direct sales force. Medinotec Inc. was incorporated in 2021 and is headquartered in Johannesburg, South Africa.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-05-31)
Health Score
Price to Earnings Ratio (P/E)
-
Medium
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Medium
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Medinotec Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-05-31)
(Last Updated 2025-05-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-05-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-05-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.